Pharmacokinetics of Trastuzumab After Subcutaneous and Intravenous Administration in Obese Patients
Sign Up to like & getrecommendations! Published in 2020 at "Annals of Pharmacotherapy"
DOI: 10.1177/1060028020902318
Abstract: Background: Subcutaneous trastuzumab (T-SC) administration does not allow the historical target concentration of 20 µg/mL for efficacy to be reached, from the start of treatment in patients with a body mass index (BMI) >30 kg/m2.… read more here.
Keywords: subcutaneous intravenous; administration; trastuzumab subcutaneous; obese patients ... See more keywords